• QuantHealth

  Participated · Series B · Aug 2026

  QuantHealth offers an AI-driven clinical trial simulation platform that enables life sciences companies to evaluate, optimize, and de-risk clinical and commercial decisions before enrolling patients or committing capital. The company serves pharmaceutical and biotechnology organizations and is led by CEO Orr Inbar. QuantHealth is based in Tel Aviv, Israel. Following its Series B, the company plans to scale enterprise-wide impact, accelerate adoption of simulation-first clinical development, advance R&D capabilities, grow its workforce, and expand its product portfolio. The article does not disclose revenues, user counts, or prior funding rounds.

• Backslash Security

  Participated · Series A · Feb 2026

  Backslash Security is a Tel Aviv-based cybersecurity company focused on protecting AI-driven software development environments. Its platform plugs into modern IDEs and coding agents such as Cursor, Claude Code, Gemini Code Assist, and GitHub Copilot, giving security teams visibility, governance, and real-time protection over AI-assisted coding activities. The product also vets and monitors Model Context Protocol (MCP) servers to ensure AI-generated code complies with organizational security and regulatory requirements. By embedding security controls directly in the developer workflow, Backslash aims to let enterprises adopt AI coding tools without increasing risk exposure. The company plans to deepen the platform’s capabilities and expand its go-to-market reach in the United States and Europe. Funds are earmarked for hiring additional R&D talent and scaling sales operations to meet rising demand from large enterprise customers. The company is led by CEO Shahar Man, and former CyberArk CRO Ron Zoran has joined the board as an independent director.

No current team members are available.